IDXX vs. BSX, SYK, MDT, BDX, EW, RMD, DXCM, STE, PODD, and BAX
Should you be buying IDEXX Laboratories stock or one of its competitors? The main competitors of IDEXX Laboratories include Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), and Baxter International (BAX). These companies are all part of the "health care equipment" industry.
IDEXX Laboratories vs.
Boston Scientific (NYSE:BSX) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.
Boston Scientific has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500. Comparatively, IDEXX Laboratories has a beta of 1.52, indicating that its stock price is 52% more volatile than the S&P 500.
Boston Scientific currently has a consensus target price of $114.74, indicating a potential upside of 9.67%. IDEXX Laboratories has a consensus target price of $536.00, indicating a potential upside of 7.19%. Given Boston Scientific's stronger consensus rating and higher probable upside, equities analysts clearly believe Boston Scientific is more favorable than IDEXX Laboratories.
89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are owned by institutional investors. 0.5% of Boston Scientific shares are owned by company insiders. Comparatively, 1.0% of IDEXX Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Boston Scientific had 15 more articles in the media than IDEXX Laboratories. MarketBeat recorded 44 mentions for Boston Scientific and 29 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.48 beat Boston Scientific's score of 1.40 indicating that IDEXX Laboratories is being referred to more favorably in the news media.
Boston Scientific has higher revenue and earnings than IDEXX Laboratories. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.
IDEXX Laboratories has a net margin of 22.78% compared to Boston Scientific's net margin of 11.07%. IDEXX Laboratories' return on equity of 55.82% beat Boston Scientific's return on equity.
Boston Scientific received 528 more outperform votes than IDEXX Laboratories when rated by MarketBeat users. However, 71.71% of users gave IDEXX Laboratories an outperform vote while only 69.94% of users gave Boston Scientific an outperform vote.
Summary
Boston Scientific beats IDEXX Laboratories on 10 of the 19 factors compared between the two stocks.
Get IDEXX Laboratories News Delivered to You Automatically
Sign up to receive the latest news and ratings for IDXX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
IDEXX Laboratories Competitors List
Related Companies and Tools
This page (NASDAQ:IDXX) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy IDXX Stock Free IDXX Stock Alerts